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IN recent years it was recognized that glucose may be dissimilated in mam-
malian tissues by a route which is distinct from the classical glycolytic (Embden-
Meyerhof) pathway, namely the hexosemonophosphate oxidative pathway (HMP
shunt). The latter reaction sequence has been studied with several techniques,
including the use of tracers in attempts to assess its quantitative significance
(compare Wood, 1955).
The HMP shunt has also been shown to be operative in manyneoplastic tissues
of widely different origin (Agranoff, Brady and Colodzin, 1954; Emmelot, Bosch
and van Vals, 1955; van Vals, Bosch and Emmelot, 1956; Bosch, van Vals and
Emmelot, 1956; van Vals and Emmelot, 1957; Abraham, Hill and Chaikoff,
1955; Abraham, Cady and Chaikof, 1956; Wenner and Weinhouse, 1956; Kit,
1956; Kit and Graham, 1956; Villavicencio and Barron, 1957). In solid and
ascites tumours the relative occurrence of the E-M pathway and HMP shunt has
been evaluated quantitatively by measuring the differential incorporation of the
carbon atoms 1 and 6 from specifically-labelled glucose into lactate or fatty acids
(Wenner and Weinhouse, 1956; Abraham et al., 1956).
In the present investigation, which was started well before the latter studies
appeared in print, a similar approach was made. After a number of preliminary
experiments (Emmelot et al., 1955) in which lactate and carbon dioxide were
isolated, we felt it necessary to check the general validity of the method by col-
lecting information about the labelling of other cellular compounds. To this end
a study was made ofthe incorporation of C14 from glucose-i-C14 and glucose-6-CL4
(G-1-C14 and G-6-C14, respectively) into the carbon dioxide, lactate, long-chain
fatty acids, cholesterol, proteins and some protein-bound amino acids of tumour
slices and ascites cells. The results of these experiments are reported below.
MATERIAL AND METHODS
Unless stated otherwise transplanted mouse tumours were used in the present
experiments. The ascites tumour (mammary carcinoma S3A obtainedfrom Dr. G.
Klein, Stockholm) was maintained in F1(BxC3H) mice. Liver tumours were in-
duced in rats of the inbred strain R-Amsterdam by feeding p-dimethylaminoazo-
benzene; a primary tumour of the mixed hepato-cholangiocellular type was used
in experiment No. 13, a transplanted (third passage) tumour of the hepato-
cellular type in experiment No. 14 and a primary tumour of the hepatocellular
type in experiment No. 20.
The incubation procedure and the isolation of the respiratory carbon dioxide,
proteins, long-chain fatty acids, cholesterol and lactate, including the chemicalMETABOLISM OF NEOPLASTIC TISSUES
degradation oflactate, has been described previously (Emmelot and Bosch, 195.5;
van Vals and Emmelot, 1957).
50-100 mg. protein was hydrolyzed with 6-10 ml. 6-NHCI at 1000 C. for
22 hours. Glutamate and aspartate were isolated over Amberlite-IR4B and a
fraction containing glycine plus alanine over Zeo-Karb 225 (Moore and Stein,
1951; Arnstein and Neuberger, 1953; Arnstein and Stankovic, 1956). An Amber-
lite IR-120 (H+) column was used to free the latter fraction from BRY 35 and
anions (Partridge, 1949 & Partridge and Westall, 1949). Glycine and alanine
were separated by paper chromatography on Whatman 3 MM paper (Arnstein
and Stankovic, 1956). The purity of the four amino acids was checked by paper
chromatography on Whatman No. 1 paper.
Amino acids and lactate were combusted to carbon dioxide and measured as
BaCO3 at " infinite " thickness. Proteins, fatty acids and cholesterol digitonide
were plated directly and their radioactivity was measured at " infinite " thickness,
and, if necessary, correction being made for self-absorption. The radioactivity of
a 1*1 cm.2 area was measured under a Geiger-Muller end-window counter under
our standard conditions. The c./m. at " infinite " thickness are listed as specific
activity.
NaHC1403 was synthesized from BaC1403. G-1-C14, G-6-C14 and G-u-C14 were
purchased from the Radiochemical Centre (Amersham). G-6-C14 was also obtained
from the United States Atomic Energy Commission. The labelled glucoses were
diluted with inactive glucose to give the desired isotope concentration.
RESULTS AND DISCUSSION
The Contribution of the HMP Shunt and the Embden-Meyerhof Pathway to
Lactate Formation from Glucose
If G-_-C14 or G-6-C14 is converted to lactate exclusively via the E-M pathway,
in which the hexose molecule is cleaved symmetrically, pyruvate-3-C14 is produced
and no radioactivity is lost. On the other hand, ifa molecule ofglucose enters the
HMP shunt, carbon atom 1 is lost early as C02 and the carbon atoms 2 and 3 as
"diose ". The resulting triose, corresponding the C-4, 5, and 6 of the original
glucose, is considered to be in equilibrium with the triose derived via the E-M
pathway. Thus, if G-1-C14 serves as substrate, the HMP shunt contributes the
unlabelled half of the glucose molecule to the lactate pool, whereas the labelled
part of the glucose enters the lactate pool in the case of G-6-C14. The specific
activities of the lactates derived from the two labelled glucoses may then serve
for the calculation of the relative contribution of the HMP shunt and E-M path-
way to the conversion ofglucose to lactate. This procedure, in which the dilution
ofthe C14 by endogenous substrates is not measured directly, has been followed in
the present paper.
The dilution of the lactate pool by unlabelled lactic acid derived from endo-
genous substrates can be calculated by measuring the specific activity of the
lactate isolated after incubation with G-u-C14. The specific activity of the lactate
derived from either G-1-C14 or G-6-C14 can then be corrected and used for calcu-
lating the relative occurrence ofthe two pathways. The latter procedure has been
introducedbyBlumenthal, Lewis andWeinhouse (1954). Inourearlierexperiments
(Emmelot, Bosch and van Vals, 1955) we had sought to account for the dilution
factor by measuring chemically the amount of lactate formed during incubation.
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This method does not account for the continuous production and removal of lac-
tate. Moreover, there was some evidence forbelieving that the presence ofglucose
sometimes stimulated lactate formation from endogenous substrate (compare
Avineri-Shapiro and Shapiro, 1956). Consequently, the correction made pre-
viously (Emmelot et al., 1955) for endogenous lactate has been too small and the
contribution of the HMP shunt, calculated on the basis of the corrected specific
activity of the lactate derived from G-1-C14, has been too high.
In the present experiments with G-1-C14 and G-6-C14 the results are expressed
as follows. Suppose that 100 molecules glucose containing a total C14-content of
A c./m. are converted to lactate; x molecules glucose pass the E-M pathway and
100-x molecules the HMP shunt. In the case ofG-1-C14 the latter fraction will not
contribute to the labelling of the lactate pool for the reasons outlined above. The
tracer reaches the lactate pool only via the E-Mpathway andthe total C14-content
of the lactate will thus amount to xA/100 c./m. When G-6-C14 is the substrate
it is assumed that no activity is lost and the total C14-content of the lactate pool
will amount to A c./m. Since,
the specific activity ofthe lactate from G-6-C14
the specific activity ofthe lactate from G-1-Cl'
total C14-content ofthe lactate from G-6-C14
total C14 content ofthe lactate from G-1-C14'
the ratio ofthe specific activities will amount to
xA/100-100/x . . (1)
x can be calculated with the data of Table I and denotes the percentage contri-
bution of the E-M pathway to the conversion of glucose to lactate. The latter
amounted to 68-100 per cent for the various tumours listed in Table I.
As might be expected from this type of experiment, rather wide variations
were encountered. In this respect and also in the quantitative results obtained
our data are not unlike those of other investigators (compare, for instance,
Abraham, Cady and Chaikoff, 1956).
In a number ofexperiments (No. 5, 7, and 9 of Table I) no contribution ofthe
HMP shunt to lactate formation was observed. Although carbon atom 1 was
oxidized in preference to carbon atom 6 of glucose (compare Table I in van Vals,
Bosch and Emmelot, 1956) in these and all other experiments, the specific acti-
vities of the lactates derived from G-6-C14 were smaller than those from G-1-C14,
and thus opposite to what must be expected on the basis ofthe assumption made
above. The specific activity ofthe glucose (5.5 x 103 c./m. as BaCO3 at " infinite "
thickness) used in the experiments of Table I was too low to permit the accurate
measurement of the C14-content of metabolic products other than lactate and
carbon dioxide.
The next six experiments (No. 10-16) were carried out with highly-labelled
G-1-C14 and G-6-C14 (1.6 x 105 c.//m. as BaCO3 at " infinite " thickness) for
90 minutes.
The lactates were isolated in four ofthe latter experiments and after chemical
degradation the isotope content of the carboxyl carbons and the remaining 2-METABOLISM OF NEOPLASTIC TISSUES
TABLE I.-Relative Contribution of the Embden-Meyerhof Pathway and Hexose-
monophosphate Shunt to the Conversion of Glucose -* Lactic Acid in Tumour
Slices
1 g. ofslices incubated with 3 mg. radioglucose (5*5 x 103 c/m as BaCO3 at
" infinite " thickness) for 60 minutes at 370 C. in 5 ml. Krebs-Ringer
phosphate buffer. Lactateisolated over a Silica-gel column and converted
to BaCO3. Specific activity as c/m at " infinite" thickness.
Glucose > Lactate
via
Specific activity of lactate ,
derived from G-n-C14 Embden-
n Meyerhoff HMPt
Experiment - pathway* shunt
Tumour number 6 (%) (%)
T 26567-sarcomatoid ovarian 1 . 3454 2340 . 68 32
tumour 2 . 2851 2337 . 83 17
T 49985-mammary carcinoma 3 . 3190 2215 . 70 30
T 86157-lympho-sarcoma . 4 . 1750 1339 . 77 23
5 . 1042 1318 . 100 0
T 5441-granulosa cell tumour 6 . 2486 1920 . 78 22
ovary 7 . 1907 2108 . 100 0
T 1014-mmmary adeno-car- 8 . 1523 1375 . 90 10
cinoma (rat)
U 256-sarcoma . . 9 . 2241 2340 . 100 0
* x offormula (1). t 100-x.
carbon skeletons were measured. From these data the specific activities of the
lactate formed from G-1-Cl4 and G-6_C14 by the mammary carcinoma T 49985,
the lymphosarcoma T 86157 and the sarcomatoid ovarian tumour T 24202 were
calculated as indicated in Table II, which illustrates the experiment with the
lymphosarcoma. Only in the latter case a slightly higher C14 content was found in
the lactate derived from G-6-014 as compared with that derived from G-1-C'4;
in the two remaining experiments rather the opposite phenomenon was observed
(compare Table III).
TABLE II.-Distribution of 014 over C, and 02 + C3 ofLactate Producedfrom
G_1_l-4 and G-6-_C4 by Slices ofthe Lymphosarcoma T 86157
Incubation during 90 minutes with 3 mg. radioglucose (7 ,uc.; 1-6 X 105
c/m as BaCO3 at " infinite " thickness) in 5 ml. Krebs-Ringer phosphate
buffer. Lactate isolated and oxidized by cerisulfate; C02 trapped as
Na2CO3 and acetaldehyde as the dimedone derivative; radioactivity
measuredafter conversiontoBaCO3. Dataexpressedas c/mat " infinite"
thickness (Experiment No. 11).
Substrate C, C2 + 0a* Lactate
G-6-C" . 1,418 . 122,148 . 81,905t G-1_C4 . 4,944 . 113,157 . 77,086t
G-u-C4 . - - . 80,289$
* Corrected by multiplying with the factor 9 to account for the dilution introduced by the carbon
of dimedone.
t Calculated as 2 (02 + 03) + C,.
4 Lactate assayed as BaCO3.
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However, it was found in all these experiments (Table II and Table III) that
the carboxyl carbons of the lactates isolated after incubation with G-1-C'4 con-
tained a higher amount of C14 than the carboxyl carbons of the lactates derived
from G-6-C14. This difference in the isotope concentration of the carboxyl groups
of the two lactates of each experiment cannot easily be explained by any of the
known reactions ofglycolysis and the citric acid cycle. A carboxylation ofribulose
diphosphate produced by the HMP shunt reactions, and the subsequent formation
of two molecules of phosphoglyceric acid by the carboxydismutase reaction
(Weissbach, Horecker and Hurwitz, 1956; Jakoby, Brumond and Ochoa, 1956;
Barron, Villavicencio and King, 1955) might account for the observed difference
inlabelling since C1402 with a higher specific activity is released fromG-i-C14than
from G-6-C14 during the incubation. However, inspection ofthe data in Table III
TABLE III.-Ratio of Specific Activities of Lactate, Carboxyl Group of Lactate and
Respiratory Carbon Dioxide Derived from G-6-C14 to the Specific Activities
of the Corresponding Compounds Derivedfrom G-i-C14
S.A. = Specific Activity.
Experiment S.A.lactatefromG-6-C"' S.A. Cl-lactate from G-6-C14 S.A. CO2from G-6-C14
number Tumour S.A.lactatefromG-1-Cld S.A. Cl-lactate from G-1-C14 S.A. C00 from G-1-C"'
10 . T49985 . 0-85 . 0 35 . 0-32
11 T 86157 1-06 . 0-28 0-38
13 . Hepatoma . 0.91 . 0-63 0 16
(rat)
15 . T 24202 . . 0-17 . 0-34
shows that the correspondence between the ratios of the C14 in the respiratory
carbon dioxide derived from G-6-C14 to that from G-1-C14, and those of the C14 in
the carboxyl groups of the lactates was not very close. Therefore, the following
two experiments were carried out with the sarcomatoid ovarian tumour T 26567
and the lymphosarcoma T 86157. 1 g. slices of each of these tumours were incu-
bated with 30 4tc NaHC'403 in the presence of unlabelled glucose for 60 minutes
at 370 C, both under aerobic and anaerobic conditions. The resulting lactate was
isolated and degraded as usual. It was concluded from the very low C14 contents
found in the latter experiments (Table IV) that the alleged C02 fixation could
not have played any significant role in the earlier experiments.
TABLE IV.-Incorporation ofNaHC'403 into the C, and C2 + C3 ofLactate by the
Sarcomatoid Ovarian Tumour T 26567
Incubation of 1 g. slices with 440 p,g. NaHC'403 (30 ,uc.) and 3 mg.
unlabelled glucose in 5 ml. Krebs-Ringer phosphate buffer for 60 minutes
370 C. in 100 per cent oxygen or nitrogen. Compare Table II for
expression ofresults.
Condition Cl C2 + C3
Aerobic . 53 . 0
Anaerobic . 56 0
Incorporation of C14from Glucose-i- and -6-C14 into Proteins,
Fatty Acids and Cholesterol
Although the ratio ofthe C14 contents ofthe two lactates derived from G-6-C14
and G-I-C14 in each of the three experiments No. 10, II and 13 appeared to beMETABOLISM OF NEOPLASTIC TISSUES
approximately equal to unity, it was found that the proteins isolated from the
same tumour slices after incubation with G-6-C14 showed a higher specific activity
than after incubation with G-1-C04 (Table V). The same was found true for the
proteins isolated in two other experiments (No. 12 and 14).
TABLE V.-Ratio ofthe Specific Activities ofthe Proteins and ofSome Amino Acids
Isolated from Tumour Slices after Incubation with GlUcose-6-C14 to the
Specific Activities of the Corresponding Compounds Labelled by the C14from
Glucose-i-C14
The actual c/m of" infinitely " thicklayers oftheproteins on 1
- 1 cm2 area
are listed between parentheses.
Experiment
number Tumour Proteins GLU ASP ALA
10 T 49985 . 1-73 (1486/862) . - . - . 22
11 . T 86157 . 1.34 (1334,997) . 1-7 . 1-4 . 1-7
12 . T 86157 . 1.81 (994/549) 1-4 . 1*3 . 1.5
13 . Rat hepatoma . 1-52 (610/401) . 1.3 . 1-4 . 2-0
14 , 2-49(10231410) 1-7 5-6 1-5
15 . T 24202 . 1-08 (9071835) . 0-8 . 1-2 . 1-3
A number of amino acids were isolated from the hydrolysates of the labelled
proteins and assayed for radioactivity. It is seen from Table V that the difference
in C14 content of the two protein fractions ofeach experiment is reflected in that
of the amino acids glutamate, aspartate and alanine. Glycine* and the essential
amino acid valine contained no or negligible radioactivity.
It was also found that a preferential incorporation of the glucose C6 into the
long-chain fatty acids and cholesterol had taken place. The ratios of the specific
activity of the latter compounds derived from G-6-0C4 to those derived from G-1-
C14 are listed in Table VI. From these data the relative contributions ofthe E-M
pathway and the HMP shunt to the conversions glucose -+ long-chains fatty
acids and glucose -+ cholesterol were calculated using formula (1); the results
are listed in Table VII. In two experiments the fatty acids derived from G-u-_C4
TABLE VI.-Ratio ofSpecific Activities of the Long-Chain Fatty Acids, Cholesterol,
and Carbon Dioxide of Tumour Slices Labelled by G-6-C14 to the Specific
Activities of the Corresponding Compounds Labelled by G-i-C'4
The per cent recovery of C14 in CO2 from G-6-C'4 and G-_-C,4 is listed in
the last column of the table between parentheses.
Experiment
number Tumour Fatty acids Cholesterol Carbon dioxide
10 . T 49985 . 2-40 . 032 (2-66/8-32)
11 . T 86157 . 1-47 . 2-70 038 (6-72/17-9)
12 T 86157 . 1-81 . 3-13 . 0-19 (2-87115-1) 13 . Rathepatoma . * . * . 0.16 (1-92/1118)
14 . . 1-60 . 1-68 . 0-37 (2-49/6 83)
15 . T 24202 . 1-42 . 1-17 . 0 34 (5-28/15.5)
* Incorporation too small to be reliable.
* This finding is in accordance with the reaction sequence: G._-C'4 or G-6-C14 - serine-
-C314
3-C'4 - glycine; serine was isolated in a few experiments and found to contain appreciable
radioactivity.
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were also isolated. Calculation based on the specific activities ofthese fatty acids
and those derived from G-1-C14 and G-6-C14 (compare Blumenthal, Lewis and
Weinhouse, 1954) yielded results in accordance with those of Table VII.
TABLE VII.-Estimation of the Relative Contributions of the Embden-Meyerhof
Pathway and HMP Shunt to the Conversion of Glucose to Fatty Acids,
Cholesterol, and Lactate
Calculation based on formula (1) and the data ofTable VI. It is assumed
thatcholesterolisexclusivelylabelledbyincorporationofthe2-0fragments
derived from glucose.
Glucose-+ Fatty acids Glucose- Cholesterol Glucose - Lactate
via via via
E-M HMP E-M HMP E-M HMP
Experiment pathway shunt pathway shunt pathway shunt
number (%) (%) (%) (%) ) )
10 . . 42 58 . 100 0
11 . 68 32 . 37 63 . 95 5
12 . 55 45 . 32 68
13 100 0
14 . 62 38 . 60 40 -
15 . 70 30 . 86 14
Comment
The quantitative estimation of the relative role of the E-M pathway and the
HMP shunt may be oflimited value in view ofthe underlying assumptions which
may appear to be wrong or too simple (compare Wood, 1955). Two observations
made in the present investigation point into the latter direction.
In a number of experiments, the specific activity of the lactate derived from
G-6-C14 was found to be lower than that formed from G-1-C14. This finding is
opposite to what must be expected on the basis ofthe assumptions made, even if
the E-M pathway were the only one in operation. A difference in the contri-
bution ofnon-labelled metabolites to lactate production in the two separate flasks
of such an experiment might contribute to the discrepancy. However, it is of
interest that Villavicencio and Barron (1957) obtained the following result which
they considered erroneous. On account of the results obtained with G-1-C14 and
G-u-C14 they calculated a contribution of 12 per cent from the HMP shunt to
lactate formation in lymphosarcoma cells, whereas with G-6-C14 no significant
contribution from the latter pathway was apparent. The results of Blumenthal
et al. (1954) also demonstrate that the contribution of the HMP shunt is smaller
when the calculation is based upon the data obtained with G-6-Cl4 and G-u-C14
than on G-1-C14 and G-u-C14.
A second discrepancy is provided by the finding that in one and the same
experiment the differential incorporation of the carbon atoms 1 and 6 of glucose
into the metabolic products of the tumour slice may vary widely as judged from
theratio ofincorporation of the labelled atomsintolactate, fattyacids, cholesterol
and proteins. It even appeared that in a number of experiments no preferential
incorporation of 06 of glucose into the lactate took place, whereas in the closely
related protein-bound alanine a strong preference was noted. This finding may
indicate that the two compounds, lactate and alanine, were not derived from the
same precursor and thus argues against the assumption that the triosephosphatesMETABOLISM OF NEOPLASTIC TISSUES
ofthe E-M pathway and the HMP shunt are in rapid metabolic equilibrium. The
present findings make it necessary to re-evaluate the validity of the assumptions
which are in general use for the quantitative estimation of the HMP shunt. A
strict quantitative significance can, as yet, not be ascribed to the available data.
The Operation ofthe HMP Shunt in Ascites Tumour Cells and
Tumour Slices as a Function ofthe Glucose Concentration
It has been reported by Racker (1956) and by Wenner, Hackney and Herbert
(1957) that the preferential incorporation of radioactivity into the respiratory
carbon dioxide from G-J-C14 as compared with G-6-C14 is dependent upon the
concentration of glucose in the medium in which ascites tumour cells are sus-
pended. With small amounts ofglucose (0.001 M) the HMP shunt did not appear
to be operative as judged by the above criterion.
We have confirmed this observation, using ascites cells of a mammary carci-
noma. No preferential incorporation ofC, or C6 ofglucoseinto the carbon dioxide,
proteins*, and fatty acids took place when the hexose concentration amounted to
0 0007 M and incubation was carried out for 30 minutes. A typical experiment is
illustrated in Table VIII, experiment No. 16a. When the glucose concentration
TABLE VIII.-Incorporation of C14 into Carbon Dioxide, Proteins and Long-Chain
Fatty Acids of Ascites Tumour Cells and Tumour Slices after Short-time
Incubation with Limiting Amounts of Glucose-l- and -6-C14
500 mg. of wet weight cells or 600 mg. of wet weight slices were incubated
for 30 minutes at 370 C. in 2'0 ml. Krebs-Ringer phosphate buffer with
250 pg. of radioglucose (5 ,uc.; 1 3 x 106 c/m as BaCO3 at " infinite"
thickness).
Carbon
dioxide Fatty
Experiment G-n-C14 C14 recovered Proteins acids
number Tumour n (%) c/m clm
16a Mammary carcinoma 1 . 21 7 . 3146 . 384
(ascites) 6 . 21 8 . 3347 . 357
16b* . Ditto . 1 . 60 . 466
6 . 3*2 . 489
16ct . ,, . 1 . 2-1 . 474
6 . 0 7 . 428
17, 18, 19 . T 86157 . 1 . 21*7 . 412 . 210
6 . 2-6 . 632 . 440
20a, b§ . Rat hepatoma . 1 . 9 1 . 270 . 105
6 . 24 . 375 . 182
21 . T 26567s . 1 . 22-4 . 1399 1861
6 . 12*6 . 1987 . 2353
* Glucose concentration raised to 0 007 M by adding 9 parts (2.25 mg.) of unlabelled glucose.
t 0*03 M malonate present.
$ Average of 3 closely agreeing experiments with different tumours of the same strain. The
per cent recovery of C14 in the carbon dioxide produced from G-1-C14 and G-6-C14 after 60 minutes of
incubation in the presence of 0 03 M malonate amounted to 31 - 3 and 0 9 respectively.
§ Average of 2 experiments with slices of the same tumour.
* The incorporation of C14 into the proteins of the ascites cells is rather high as compared
with other tumours. Calculations showed that approximately 9 per cent of the added radioactivity
was incorporated into the proteins of the ascites cells in the present experiments. In other experi-
ments, not reported here, 18 per cent ofthe radioactivity of 125jug. glucose (0 00035 M) was recovered
in the proteins.
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was raised to 0 007 M (by adding 9 parts of unlabelled glucose, Table VII, experi-
ment No. 16b), the C1 ofglucose appeared in a higher concentration in the carbon
dioxide than the C6 ofglucose (compare also experiment 4 of Table II in van Vals
and Emmelot, 1957) but the labelling of the protein by the two substrates was
not different. It should be noted that in experiments of the type 16a 22-26 per
cent ofthe C14from 250 ,tg. G-1-0C4 andin theexperimentsoftype 16b 6-8 per cent
of the C14 from 2500 ,ug. G-1-C14 was recovered in the respiratory carbon dioxide.
Inhibition of the citric acid cycle by malonate (0.03 M, Table VII, experiment
No. 16c) depressed the appearance ofC14 in the C02 from both G-1-C14 and G-6-C14
(0.0007 M) significantly, but the conversion of G-6-C14 to C1402 was impaired to a
greater extent than the corresponding process in which G-j-C14 participated;
protein labelling by the two glucoses was affected to the same extent in the pre-
sence of malonate. This effect of malonate on the incorporation of 014 from
G-1-C14 and G-6-C14 into carbon dioxide by the ascites cells was similar to that
obtained earlier with a number of normal tissues (1 g. slices) in which otherwise
no preferential oxidation of C0 of G-1-C14 (3 mg.) occurred (van Vals, Bosch and
Emmelot, 1956). In contrast with the situation in the ascites tumour, it was
found (Table VIII, experiments 17-21) that in slices of solid tumours the HMP
shunt was very active at the low glucose concentration (0.0007 M; 0-25 mg.
glucose/600 mg. wet weight of slices). The preferential incorporation of glucose
carbon atom 1 into the carbon dioxidet and of glucose carbon atom 6 into the
proteins and fatty acids, observed in the latter experiments, was very similar
to the results obtained in the earlier experiments of the present investigation in
which 3 mg. glucose/1000 mg. wet weight of slices was used.
SUMMARY
1. Tissue slices from mouse and rat tumours were incubated in the presence
of glucose-l- and -6-C14 and the C14 contents of the respiratory carbon dioxide,
lactate, long-chain fatty acids, cholesterol, proteins and some protein-bound
amino acids were measured.
2. The relative contributions of the Embden-Meyerhof pathway and the
hexosemonophosphate shunt to the conversions of glucose to lactate, fatty acids
and cholesterol were estimated by calculation based on the above data. Of the
glucose molecules which contributedtheir carbon to the lactate pools ofthe various
tumours 0-32 per cent had passed the HMP shunt. In the case of the fatty acids
and cholesterol the contribution of the HMP shunt amounted to 25-45 per cent
and 14-68 per cent, respectively. In all but one experiment a higher incorporation
of C6 as compared with the CQ ofglucose into the proteins was noted. The differ-
ence in labelling of the proteins by the two glucoses was reflected in the specific
activities of the constituent amino acids glutamate, aspartate and alanine.
3. The ratio of incorporation of carbon atom 6 to that of carbon atom 1 of
glucose into the various metabolic products of the tumour slices varied widely.
The finding that in a number of experiments this ratio amounted to 1 or less in
the case of lactate and to 1-5-2-2 for alanine raises the question whether the triose
produced by the E-M pathway is in rapid metabolic equilibrium with the triose
produced by the HMP shunt reactions. It is concluded that the validity of the
t Earlier experiments (van Vals et al., 1956) have shown that the recovery of C14 in the carbon dioxide produced in the presence of G-1-C14 by slices of solid tumours is insensitive, or almost
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assumptions which are in general use to-day for the calculation ofthe HMP shunt
in tracer experiments, should be re-evaluated.
4. A difference in labelling of the carboxyl carbons of the lactate produced
from glucose-l- and _6_C14 was observed. The reason for this remained obscure
since fixation ofC14-bicarbonate into the carboxyl carbons of lactate did not take
place to any significant extent under the conditions ofthe present experiments.
5. In contrast to the situation in ascites tumour cells, the activity ofthe HMP
shunt, as judged by the preferential incorporation of the C6 of glucose into the
proteins and fatty acids and that of C1 into the carbon dioxide, was not impaired
in slices of solid tumours when incubation was carried out at very low glucose
concentrations. This may indicate that the HMP shunt of solid tumours is
operative at physiological concentrations of glucose.
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